Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACKR3 | P25106 | 3/20 | 0.37 |
| ▸ | GPR4 | P46093 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.35 |
| ▸ | DRD2 | P14416 | 3/20 | 0.34 |
| ▸ | DRD3 | P35462 | 3/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2987312 | 0.97 | ACKR3 (0.39) | ACKR3GPR4EPHX2GPR119PDE3B | |
| SCHEMBL2983812 | 0.92 | PDE3B (0.36) | PDE3BPDE3ADRD2DRD3 | |
| SCHEMBL2980444 | 0.89 | DRD3 (0.37) | PDE3BPDE3ADRD2DRD3 | |
| SCHEMBL2983864 | 0.87 | PDE3B (0.36) | PDE3BPDE3ADRD2DRD3 | |
| SCHEMBL2980471 | 0.86 | PDE3B (0.40) | PDE3BPDE3ADRD2DRD3MAOB | |
| SCHEMBL2973307 | 0.86 | PDE3B (0.41) | PDE3BPDE3ADRD2DRD3MAOB | |
| SCHEMBL2980391 | 0.86 | PDE3B (0.42) | PDE3BPDE3AMAOB | |
| SCHEMBL2975965 | 0.85 | CACNA2D1 (0.38) | PDE3BPDE3A | |
| SCHEMBL2983292 | 0.82 | GPR119 (0.38) | GPR119 | |
| SCHEMBL2975929 | 0.82 | PDE3B (0.34) | PDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1831207-A1 | AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | Amgen Inc. (US) | 2007-09-12 | — | — | EP | disclosed |
| WO-2006066172-A1 | AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | AMGEN, INC. (US) | 2006-06-22 | — | — | WO | disclosed |